Published in Am J Surg on October 01, 1998
Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis (2007) 2.30
Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer (2007) 1.57
Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer (2010) 1.31
Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol (2005) 1.28
Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. World J Gastroenterol (2006) 1.26
C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci (2004) 1.14
Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer. Br J Cancer (2004) 1.14
Clinical utility of peri-operative C-reactive protein testing in general surgery. Ann R Coll Surg Engl (2008) 1.11
Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma. Surg Today (2008) 1.11
Prognostic role of C-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis. Int J Med Sci (2013) 1.06
Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer. Surg Today (2011) 1.06
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One (2015) 1.03
C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results. Urol Oncol (2010) 1.02
Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase. Br J Cancer (2004) 1.02
Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer. Yonsei Med J (2012) 0.98
Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer. Br J Cancer (2010) 0.97
Circulating C-reactive protein and colorectal cancer risk: a report from the Shanghai Men's Health Study. Carcinogenesis (2013) 0.95
Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer. Oncotarget (2016) 0.93
The effect of deprivation and the systemic inflammatory response on outcome following curative resection for colorectal cancer. Br J Cancer (2003) 0.92
Prognostic significance of preoperative C-reactive protein elevation and thrombocytosis in patients with non-metastatic renal cell carcinoma. Korean J Urol (2011) 0.91
C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion. World J Surg Oncol (2013) 0.90
Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response. World J Surg (2009) 0.90
Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer (2006) 0.89
Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery. Dig Dis Sci (2015) 0.89
Prognostic significance of the preoperative serum C-reactive protein level in patients with stage IV colorectal cancer. Surg Today (2014) 0.88
Preoperative elevation of serum C--reactive protein is predictive for prognosis in myeloma bone disease after surgery. Br J Cancer (2006) 0.88
The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases. Ann Surg Oncol (2014) 0.88
A prospective study on C-reactive protein as a prognostic factor for survival time of terminally ill cancer patients. Support Care Cancer (2007) 0.87
Inflammation-based factors and prognosis in patients with colorectal cancer. World J Gastrointest Oncol (2015) 0.87
Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer. Exp Ther Med (2010) 0.86
A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol Biomarkers Prev (2014) 0.86
Impact of serum C-reactive protein level on the prognosis of patients with hepatocellular carcinoma undergoing TACE. Clin Mol Hepatol (2013) 0.84
The association between preoperative serum C-reactive protein and hepatocellular carcinoma recurrence in patients with chronic hepatitis B virus (HBV) infection--a retrospective study. PLoS One (2015) 0.83
C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World J Gastroenterol (2006) 0.83
Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study. Cancer Epidemiol Biomarkers Prev (2015) 0.81
Evaluation of preoperative C-reactive protein aids in predicting poor survival in patients with curative colorectal cancer with poor lymph node assessment. Oncol Lett (2013) 0.80
Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis. Ther Clin Risk Manag (2015) 0.80
Mannose-binding lectin and maladies of the bowel and liver. World J Gastroenterol (2006) 0.79
Remodeling of the immunoinflammatory network system in elderly cancer patients: implications of inflamm-aging and tumor-specific hyperinflammation. Surg Today (2008) 0.78
Preoperative Serum Interleukin-6 Is a Potential Prognostic Factor for Colorectal Cancer, including Stage II Patients. Gastroenterol Res Pract (2015) 0.78
Evaluation correlates C-reactive protein with advanced stage Hodgkin's lymphoma and response to treatment in a tertiary university hospital in Brazil. Rev Bras Hematol Hemoter (2015) 0.77
Factors Influencing Survival in Stage IV Colorectal Cancer: The Influence of DNA Ploidy. ISRN Gastroenterol (2013) 0.77
Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions. Yonsei Med J (2013) 0.76
Interleukin-8 producing hepatocellular carcinoma with pyrexia. HPB Surg (2009) 0.76
Atrial fibrillation and survival in colorectal cancer. World J Surg Oncol (2004) 0.76
Clinical and prognostic significance of pathological and inflammatory markers in the surgical treatment of locally advanced colorectal cancer. Onco Targets Ther (2015) 0.75
The prognostic significance of the preoperative full blood count after resection of colorectal liver metastases. HPB Surg (2009) 0.75
Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis. Oncol Lett (2017) 0.75
Expression of C-Reactive Protein in Rectal Cancer. Gastroenterology Res (2009) 0.75
Factors Associated with Short-Term Mortality After Surgical Oncologic Emergencies. Ann Surg Oncol (2015) 0.75
Wheel Balanced Cancer Therapy for Longer Than 21 Days Can Have a Positive Effect on the Survival of Patients with Stage IV Cancer. J Pharmacopuncture (2015) 0.75
Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma. Int Surg (2014) 0.75
Pre-treatment blood inflammatory markers as predictors of systemic infection during induction chemotherapy: results of an exploratory study in patients with acute myeloid leukemia. Support Care Cancer (2015) 0.75
Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc (1994) 6.86
Construction of adenovirus vectors through Cre-lox recombination. J Virol (1997) 6.72
Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients. Eur J Cancer (1998) 3.81
Mini-laparoscopic appendectomy using a needle loop retractor offers optimal cosmetic results. Surg Endosc (2004) 3.38
Purification and some properties of Clostridium botulinum type-E toxin. Biochim Biophys Acta (1968) 2.87
Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg (1999) 2.86
Complications and diagnosis of Meckel's diverticulum in 776 patients. Am J Surg (1992) 2.48
Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis. Am J Surg (1988) 2.31
A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenism. Performing a hepatectomy after a laparoscopic splenectomy. Surg Endosc (2000) 2.30
Activity differentially regulates the surface expression of synaptic AMPA and NMDA glutamate receptors. Proc Natl Acad Sci U S A (1998) 2.28
Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. Mol Biol Cell (1999) 2.26
Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg (2000) 2.13
Detection of active cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reaction. J Vasc Surg (1994) 2.13
High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer (2000) 2.08
Bile leakage after hepatic resection. Ann Surg (2001) 2.08
Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg (1984) 2.07
Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol (2000) 2.00
Wnt-1 induces growth, cytosolic beta-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts. Mol Cell Biol (1998) 1.98
Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group. Br J Cancer (2000) 1.93
Needle and trocar injury during laparoscopic surgery in Japan. Surg Endosc (1997) 1.92
Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg (2001) 1.90
Germ-line transmission and developmental regulation of a 150-kb yeast artificial chromosome containing the human beta-globin locus in transgenic mice. Proc Natl Acad Sci U S A (1993) 1.88
Significance of 12S toxin of Clostridium botulinum type E. J Bacteriol (1969) 1.87
Solitary Peutz-Jeghers type polyp of the stomach in the absence of familial polyposis coli in a teenage boy. Endoscopy (1989) 1.86
Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery (1995) 1.82
Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg (1981) 1.79
Quality of life after gastrectomy in patients with carcinoma of the stomach. Br J Surg (1992) 1.76
Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg (1997) 1.76
Pathway of chymotrypsin evolution suggested by the structure of the FMN-binding protein from Desulfovibrio vulgaris (Miyazaki F) Nat Struct Biol (1997) 1.75
Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy (2008) 1.73
Predictors of lymph node metastasis in early gastric cancer. Br J Surg (1992) 1.73
Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology (1995) 1.72
Pathological appearance of the stomach after endoscopic mucosal resection for early gastric cancer. Br J Surg (1997) 1.71
Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res (2000) 1.69
Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer (1997) 1.67
Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer (2000) 1.67
Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology (1996) 1.64
Remitting seronegative symmetrical synovitis with pitting edema associated with gastric carcinoma. J Rheumatol (1997) 1.64
Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol (2002) 1.64
Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology (1991) 1.63
Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging (1996) 1.59
Gastric carcinoma in patients over 70 years of age. Br J Surg (1995) 1.59
Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma. Hepatology (1989) 1.58
Correlation between metastatic site, histological type, and serum tumor markers of gastric carcinoma. Hum Pathol (1995) 1.57
Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery (2000) 1.55
Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. J Hepatol (2001) 1.54
A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology (1989) 1.53
Inflammatory pseudotumor of the lung in adults: radiographic and clinicopathological analysis. Ann Thorac Surg (1989) 1.53
mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathway. Cell Death Differ (2011) 1.52
Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer (1996) 1.52
Laparoscopic splenectomy. Am J Surg (1994) 1.52
Alternate hemihepatic vascular control technique for hepatic resection. Am J Surg (1993) 1.51
Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy. Hepatology (1994) 1.51
Clinical management of recurrent hepatocellular carcinoma after primary resection. Br J Surg (1988) 1.50
Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. Biochem J (1998) 1.50
Effects of endoscopic injection sclerotherapy on portal hypertensive gastropathy: a prospective study. Gastrointest Endosc (1992) 1.49
Usefulness of preoperative transvaginal ultrasonography for women with advanced gastric carcinoma. Am J Gastroenterol (1999) 1.49
Changes in the caudate lobe that is transplanted with extended left lobe liver graft from living donors. Surgery (2001) 1.49
Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Ann Thorac Surg (1990) 1.46
Results of 280 liver resections for hepatocellular carcinoma. Arch Surg (1996) 1.45
Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol (1992) 1.45
Familial occurrence of electrocardiographic abnormalities of the Brugada-type. Intern Med (1996) 1.45
Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer. Br J Cancer (2000) 1.45
Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas. Br J Cancer (2001) 1.44
Signet ring cell carcinoma of the stomach. Cancer (1992) 1.44
Endothelium-derived relaxing factor and vein grafts. Br J Surg (1991) 1.43
Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology (1992) 1.42
Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest (1999) 1.42
Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010. Infection (2013) 1.42
Laparoscopic repair for perforation of duodenal ulcer with omental patch: report of initial six cases. Surg Laparosc Endosc (1998) 1.42
Transitional mucosa in human colorectal lesions. Dis Colon Rectum (1990) 1.42
Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1. Am J Physiol (1996) 1.42
A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. Proc Natl Acad Sci U S A (1998) 1.42
Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery (1996) 1.41
Hydrogen peroxide induces midzonal heat shock protein 72 and apoptosis in sinusoidal endothelial cells of hypoxic rat liver. Crit Care Med (2000) 1.41
Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial. Surgery (1988) 1.41
Biologic characteristics of esophageal epithelial dysplasia assessed by proliferating cell nuclear antigen. Cancer (1996) 1.41
Laparoscopic splenectomy with an ultrasonic dissector. N Engl J Med (1992) 1.41
Diagnosis of inflammatory pseudotumor of the liver: value of CT. AJR Am J Roentgenol (1994) 1.40
Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res (2000) 1.40
p27 expression and gastric carcinoma. Nat Med (1997) 1.40
Acute gastric anisakiasis. Analysis of 178 cases. JAMA (1985) 1.40
Graft replacement of pararenal inferior vena cava for leiomyosarcoma with the use of venous bypass. Surgery (1993) 1.40
Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg (1998) 1.40
Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res (1996) 1.39
Endoscopic classification of gastric varices. Gastrointest Endosc (1990) 1.39
A small polypoid lesion in the lower common bile duct: a case study. Endoscopy (1994) 1.39
Non-penetrating vascular clips anastomosis inhibited intimal thickening under poor runoff conditions in canine autogenous vein grafts. Eur J Vasc Endovasc Surg (2001) 1.39
Effectiveness of extended lymphadenectomy in noncurative gastrectomy. Am J Surg (1995) 1.39
The human beta globin locus introduced by YAC transfer exhibits a specific and reproducible pattern of developmental regulation in transgenic mice. Blood (1997) 1.39
Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient mice: redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinases. Mol Cell Biol (2001) 1.39